699 related articles for article (PubMed ID: 34261617)
41. Protected complex percutaneous coronary intervention and transcatheter aortic valve replacement using extracorporeal membrane oxygenation in a high-risk frail patient: a case report.
Kmiec L; Holzamer A; Fischer M; Debl K; Zerdzitzki M; Schmid C; Maier L; Hilker M; Sossalla S
J Med Case Rep; 2020 Sep; 14(1):163. PubMed ID: 32962754
[TBL] [Abstract][Full Text] [Related]
42. Outcomes of patients with myocardial infarction who underwent orbital atherectomy for severely calcified lesions.
Lee MS; Shlofmitz E; Lluri G; Kong J; Neverova N; Shlofmitz R
Cardiovasc Revasc Med; 2017; 18(7):497-500. PubMed ID: 28529094
[TBL] [Abstract][Full Text] [Related]
43. Incidence, Technical Safety, and Feasibility of Coronary Angiography and Intervention Following Self-expanding Transcatheter Aortic Valve Replacement.
Tanaka A; Jabbour RJ; Testa L; Agnifili M; Ettori F; Fiorina C; Adamo M; Bruschi G; Giannini C; Petronio AS; Barbanti M; Tamburino C; De Felice F; Reimers B; Poli A; Colombo A; Latib A
Cardiovasc Revasc Med; 2019 May; 20(5):371-375. PubMed ID: 30857975
[TBL] [Abstract][Full Text] [Related]
44. Safety and feasibility of PCI in patients undergoing TAVR: A systematic review and meta-analysis.
Bajaj A; Pancholy S; Sethi A; Rathor P
Heart Lung; 2017; 46(2):92-99. PubMed ID: 28088437
[TBL] [Abstract][Full Text] [Related]
45. TransCatheter aortic valve implantation and fractional flow reserve-guided percutaneous coronary intervention versus conventional surgical aortic valve replacement and coronary bypass grafting for treatment of patients with aortic valve stenosis and multivessel or advanced coronary disease: The transcatheter valve and vessels trial (TCW trial): Design and rationale.
Kedhi E; Rroku A; Hermanides RS; Dambrink JH; Singh S; Berg JT; van Ginkel DJ; Hudec M; Amoroso G; Amat-Santos IJ; Andreas M; Teles RC; Bonnet G; Van Belle E; Conradi L; van Garsse L; Wojakowski W; Voudris V; Sacha J; Cervinka P; Lipsic E; Somi S; Nombela-Franco L; Postma S; Piayda K; De Luca G; Malinofski K; Modine T
Am Heart J; 2024 Apr; 270():86-94. PubMed ID: 38309610
[TBL] [Abstract][Full Text] [Related]
46. Impact of untreated chronic obstructive coronary artery disease on outcomes after transcatheter aortic valve replacement.
Persits I; Layoun H; Kondoleon NP; Spilias N; Badwan O; Sipko J; Yun JJ; Kalra A; Dykun I; Tereshchenko LG; Krishnaswamy A; Reed GW; Kapadia SR; Puri R
Eur Heart J; 2024 Jun; 45(21):1890-1900. PubMed ID: 38270189
[TBL] [Abstract][Full Text] [Related]
47. Impact of residual coronary atherosclerosis on transfemoral transcatheter aortic valve replacement.
Li J; Patel SM; Nadeem F; Thakker P; Al-Kindi S; Thomas R; Makani A; Hornick JM; Patel T; Lipinski J; Ichibori Y; Davis A; Markowitz AH; Bezerra HG; Simon DI; Costa MA; Kalra A; Attizzani GF
Catheter Cardiovasc Interv; 2019 Feb; 93(3):545-552. PubMed ID: 30312990
[TBL] [Abstract][Full Text] [Related]
48. Impact of Coronary Artery Disease Severity Assessed With the SYNTAX Score on Outcomes Following Transcatheter Aortic Valve Replacement.
Paradis JM; White JM; Généreux P; Urena M; Doshi D; Nazif T; Hahn R; George I; Khalique O; Harjai K; Lasalle L; Labbé BM; DeLarochellière R; Doyle D; Dumont É; Mohammadi S; Leon MB; Rodés-Cabau J; Kodali S
J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28219920
[TBL] [Abstract][Full Text] [Related]
49. Clinical Outcomes of Transcatheter Aortic Valve Replacement With and Without Percutaneous Coronary Intervention-An Updated Meta-Analysis and Systematic Review.
Yassen M; Moustafa A; Venkataramany B; Schodowski E; Royfman R; Eltahawy E
Curr Probl Cardiol; 2023 Nov; 48(11):101980. PubMed ID: 37473936
[TBL] [Abstract][Full Text] [Related]
50. Transcatheter aortic valve replacement and percutaneous coronary intervention versus surgical aortic valve replacement and coronary artery bypass grafting in patients with severe aortic stenosis and concomitant coronary artery disease: A systematic review and meta-analysis.
Kotronias RA; Bray JH; Scarsini R; Rajasundaram S; Terentes-Printzios D; De Maria GL; Kharbanda RK; Mamas MA; Bagur R; Banning AP
Catheter Cardiovasc Interv; 2020 Nov; 96(5):1113-1125. PubMed ID: 32662594
[TBL] [Abstract][Full Text] [Related]
51. Long-term risk of unplanned percutaneous coronary intervention after transcatheter aortic valve replacement.
Okuno T; Demirel C; Tomii D; Heg D; Häner J; Siontis GCM; Lanz J; Räber L; Strotecky S; Fürholz M; Praz F; Windecker S; Pilgrim T
EuroIntervention; 2022 Nov; 18(10):797-803. PubMed ID: 36039573
[TBL] [Abstract][Full Text] [Related]
52. Degenerative Severe Aortic Stenosis and Concomitant Coronary Artery Disease: What Is Changing in the Era of the "Transcatheter Revolution"?
Pepe M; Larosa C; Rosa I; Biondi-Zoccai G; Nestola PL; Di Cillo O; Bortone AS; Giordano A; Favale S
Curr Atheroscler Rep; 2020 May; 22(5):17. PubMed ID: 32451750
[TBL] [Abstract][Full Text] [Related]
53. Orbital atherectomy safety and efficacy: A comparative analysis of ostial versus non-ostial calcified coronary lesions.
Ghazzal A; Martinsen BJ; Sendil S; Torres CA; Croix GS; Sethi P; Cipriano R; Kirtane AJ; Leon MB; Beohar N
Cardiovasc Revasc Med; 2024 Jan; 58():52-57. PubMed ID: 37482450
[TBL] [Abstract][Full Text] [Related]
54. Outcomes After Coronary Orbital Atherectomy at Centers Without On-Site Surgical Backup: Diabetics Versus Non-Diabetics and Impact of Access Site.
Rao LG; Rao AM; Rao SP; Rao R; Bhavsar JH; Liu WY; Igyarto Z; Martinsen BJ
Cardiovasc Revasc Med; 2021 Sep; 30():20-25. PubMed ID: 33077394
[TBL] [Abstract][Full Text] [Related]
55. Comparison of rotational and orbital atherectomy for the treatment of calcific coronary lesions: Insights from the VA clinical assessment reporting and tracking (CART) program.
Barrett C; Warsavage T; Kovach C; McGuinn E; Plomondon ME; Armstrong EJ; Waldo SW
Catheter Cardiovasc Interv; 2021 Feb; 97(2):E219-E226. PubMed ID: 32449836
[TBL] [Abstract][Full Text] [Related]
56. Procedural and Long-Term Ischemic Outcomes of Tight Subtotal Occlusions Treated with Orbital Atherectomy: An ORBIT II Subanalysis.
Lee MS; Shlofmitz RA; Shlofmitz E; Behrens AN; Revtyak G; Martinsen BJ; Chambers JW
Cardiovasc Revasc Med; 2019 Jul; 20(7):563-568. PubMed ID: 30243964
[TBL] [Abstract][Full Text] [Related]
57. Periprocedural Myocardial Injury and Coronary Artery Disease in Patients Undergoing Transcatheter Aortic Valve Replacement.
Dagan M; Dawson LP; Stehli J; Koh JQS; Quine E; Stub D; Htun NM; Walton A; Duffy SJ
Cardiovasc Revasc Med; 2022 Feb; 35():8-15. PubMed ID: 33863658
[TBL] [Abstract][Full Text] [Related]
58. Clinical outcomes and revascularization strategies in patients with low-flow, low-gradient severe aortic valve stenosis according to the assigned treatment modality.
O'Sullivan CJ; Englberger L; Hosek N; Heg D; Cao D; Stefanini GG; Stortecky S; Gloekler S; Spitzer E; Tüller D; Huber C; Pilgrim T; Praz F; Buellesfeld L; Khattab AA; Carrel T; Meier B; Windecker S; Wenaweser P
JACC Cardiovasc Interv; 2015 Apr; 8(5):704-17. PubMed ID: 25946444
[TBL] [Abstract][Full Text] [Related]
59. Two-year outcomes after treatment of severely calcified coronary lesions with the orbital atherectomy system and the impact of stent types: Insight from the ORBIT II trial.
Généreux P; Bettinger N; Redfors B; Lee AC; Kim CY; Lee MS; Shlofmitz RA; Moses JW; Stone GW; Chambers JW
Catheter Cardiovasc Interv; 2016 Sep; 88(3):369-77. PubMed ID: 27084293
[TBL] [Abstract][Full Text] [Related]
60. Transcatheter or surgical treatment of severe aortic stenosis and coronary artery disease: A comparative analysis from the Italian OBSERVANT study.
Barbanti M; Buccheri S; Capodanno D; D'Errigo P; Ranucci M; Rosato S; Santoro G; Fusco D; Tamburino C; Biancari F; Seccareccia F;
Int J Cardiol; 2018 Nov; 270():102-106. PubMed ID: 29903519
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
